Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) just unveiled an announcement.
Recordati S.p.A. has provided an update on its share buyback program, initiated to support stock options and performance share plans for its management. Between October 13 and October 17, 2025, the company purchased 56,725 of its own shares, bringing its total holdings to 4,597,656 shares, which is 2.199% of its share capital. This strategic move is likely to enhance stakeholder value and align management incentives with company performance.
The most recent analyst rating on (IT:REC) stock is a Sell with a EUR50.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, originating from a family-run pharmacy in Northern Italy in the 1920s. The company offers therapeutic options in both general and specialist medicine segments, as well as for rare diseases. It operates in a fully integrated manner from clinical development to production, marketing, and licensing of active pharmaceutical ingredients and finished products, with a presence in about 150 countries across EMEA, Americas, and APAC regions, employing over 4,580 people worldwide.
Average Trading Volume: 235,975
Technical Sentiment Signal: Buy
Current Market Cap: €10.66B
For an in-depth examination of REC stock, go to TipRanks’ Overview page.